Our Digital Health group guides companies through the myriad considerations they encounter as the delivery of healthcare becomes increasingly digital.
As private equity investment in the Life Sciences and Healthcare industry continues to increase, our cohesive regulatory and transactional approach helps ensure success through each phase of investment.
We provide 360-degree support to companies that develop, manufacture and distribute products tailored specifically toward improving women’s health, from start-ups to global corporations.
King & Spalding partner Mark Polston discusses hospital price transparency.Watch Now
King & Spalding partners Sally Yates and Mike Paulhus discuss key developments in healthcare fraud and abuse enforcement.Watch Now
King & Spalding partner Amanda Hayes-Kibreab explains ways that healthcare providers can successfully challenge commercial payors’ reimbursement policies.Watch Now
Our Sunshine and State Law Compliance Group serves as a powerful industry advocate with respect to transparency laws for more than 100 members companies.
We established the Surprise Billing and Price Transparency Group to assist our clients in developing solutions to changes in healthcare transparency laws.
The K&S International Ad Hoc Group is a coalition of 20+ pharma and medical device companies that focuses on international transparency/disclosure laws targeting manufacturers.
Chambers USA 2022
LMG Life Sciences
LMG Life Sciences
November 1, 2023
President Biden's Executive Order on AI - Legal Practice Snapshots
October 23, 2023
How Int'l Regulatory Collabs Can Expedite Pharma Approvals
August 1, 2023
TransMedics to Acquire Summit Aviation
May 2, 2023
Dutscher group to acquire Ozyme in France